Zetia | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Zetia
U.S. EXCLUSIVITIES

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Zetia

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 29 USDMF, 11 JDMF, 16 EU WC, 61 KDMF, 18 NDC API, 50 Listed Suppliers, $ API Reference Price

77 API Suppliers
29 USDMF
11 JDMF
16 EU WC
61 KDMF
18 NDC API
50 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

34 Intermediates Suppliers

34 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

602 FDF Dossiers, 62 FDA Orange Book, 357 Europe, 22 Canada, 19 Australia, 41 South Africa, 101 Listed Dossiers

602 FDF Dossiers
62 FDA Orange Book
357 Europe
22 Canada
19 Australia
41 South Africa
101 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 10MG
TABLET;ORAL - 10MG;10MG
TABLET;ORAL - 10MG;20MG
TABLET;ORAL - 10MG;40MG
TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 6 SPI Pharma, 4 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 NEWEDGE Overseas, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 41 Direct Compression, 27 Granulation, 25 Controlled & Modified Release, 23 Lubricants & Glidants, 18 Thickeners and Stabilizers, 16 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Solubilizers, 9 Film Formers & Plasticizers, 9 Taste Masking, 7 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Parenteral, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Topical, 1 Surfactant & Foaming Agents

72 Fillers, Diluents & Binders
47 Coating Systems & Additives
44 Disintegrants & Superdisintegrants
41 Direct Compression
27 Granulation
25 Controlled & Modified Release
23 Lubricants & Glidants
18 Thickeners and Stabilizers
16 Co-Processed Excipients
11 Chewable & Orodispersible Aids
10 Solubilizers
9 Film Formers & Plasticizers
9 Taste Masking
7 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Parenteral
4 Vegetarian Capsules
4 Emulsifying Agents
3 Rheology Modifiers
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 109 NEWS #PharmaBuzz

8 DATA COMPILATION #PharmaFlow
109 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 330 Finished Drug Prices, 38 Annual Reports

3 US Medicaid Prescriptions
330 Finished Drug Prices
38 Annual Reports

MARKET PLACE

19 APIs, 5 FDF Dossiers

19 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

19 US Patents
3 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

2 USP
2 Others

ANALYTICAL

6 BioAnalytical Methods

6 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,330 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3ESPERION THERAPS INC

filter Product Reset all filters

3 All

01 3BEMPEDOIC ACID; EZETIMIBE

filter Exclusivity Expiration Date Reset all filters

3 All

01 12025-02-21

02 22027-03-22

filter Exclusivity Code Reset all filters

3 All

01 1I-943

02 1I-945

03 1NCE

Product Main Page

ESPERION THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BEMPEDOIC ACID; EZETIMIBE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-945

Exclusivity Expiration Date

2027-03-22

Application Number

211617

Product Number

1

Exclusivity Details

01

ESPERION THERAPS INC

BEMPEDOIC ACID; EZETIMIBE

American Pharma Summit

Not Confirmed

ESPERION THERAPS INC

U.S.A

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BEMPEDOIC ACID; EZETIMIBE

Exclusivity Code : I-945

Exclusivity Expiration Date : 2027-03-22

Application Number : 211617

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ESPERION THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BEMPEDOIC ACID; EZETIMIBE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-943

Exclusivity Expiration Date

2027-03-22

Application Number

211617

Product Number

1

Exclusivity Details

02

ESPERION THERAPS INC

BEMPEDOIC ACID; EZETIMIBE

American Pharma Summit

Not Confirmed

ESPERION THERAPS INC

U.S.A

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BEMPEDOIC ACID; EZETIMIBE

Exclusivity Code : I-943

Exclusivity Expiration Date : 2027-03-22

Application Number : 211617

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ESPERION THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BEMPEDOIC ACID; EZETIMIBE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2025-02-21

Application Number

211617

Product Number

1

Exclusivity Details

03

ESPERION THERAPS INC

BEMPEDOIC ACID; EZETIMIBE

American Pharma Summit

Not Confirmed

ESPERION THERAPS INC

U.S.A

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BEMPEDOIC ACID; EZETIMIBE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2025-02-21

Application Number : 211617

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?